首页> 外文OA文献 >A simple method to identify kinases that regulate embryonic stem cell pluripotency by high-throughput inhibitor screening
【2h】

A simple method to identify kinases that regulate embryonic stem cell pluripotency by high-throughput inhibitor screening

机译:一种通过高通量抑制剂筛选来鉴定调节胚胎干细胞多能性的激酶的简单方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Embryonic stem cells (ESCs) can self-renew or differentiate into all cell types, a phenomenon known as pluripotency. Distinct pluripotent states have been described, termed “naïve” and “primed” pluripotency. The mechanisms that control naïve-primed transition are poorly understood. In particular, we remain poorly informed about protein kinases that specify naïve and primed pluripotent states, despite increasing availability of high-quality tool compounds to probe kinase function. Here, we describe a scalable platform to perform targeted small molecule screens for kinase regulators of the naïve-primed pluripotent transition in mouse ESCs. This approach utilizes simple cell culture conditions and standard reagents, materials and equipment to uncover and validate kinase inhibitors with hitherto unappreciated effects on pluripotency. We discuss potential applications for this technology, including screening of other small molecule collections such as increasingly sophisticated kinase inhibitors and emerging libraries of epigenetic tool compounds.
机译:胚胎干细胞(ESC)可以自我更新或分化为所有细胞类型,这种现象称为多能性。已经描述了不同的多能状态,称为“幼稚的”和“原始的”多能性。控制幼稚的过渡的机制了解甚少。特别是,尽管增加了用于检测激酶功能的高质量工具化合物的可用性,但对于指定幼稚和引发多能态的蛋白激酶,我们仍然知之甚少。在这里,我们描述了一个可扩展的平台,可以对小鼠ESC中天真的引发的多能性转换的激酶调节剂进行靶向的小分子筛选。这种方法利用简单的细胞培养条件和标准试剂,材料和设备来发现和验证迄今为止对多能性没有明显影响的激酶抑制剂。我们讨论了这项技术的潜在应用,包括筛选其他小分子集合,例如日益复杂的激酶抑制剂和表观遗传工具化合物的新兴库。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号